| Name | NWP-0476 |
|---|---|
| Synonyms | Benzamide, 4-[4-[[2-(4-chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-2-(3,4-dihydro-2H-pyrrolo[3′,2′:5,6]pyrido[2,3-b][1,4]oxazin-1(7H)-yl)-N-[[4-[[(2R)-1,4-dioxan-2-ylmethyl]amino]-3-nitrophenyl]sulfonyl] |
| Description | NWP-0476 is BCL-2/BCL-xL inhibitor. NWP-0476 has a modified structure with fine-tuned BCL-xL activity. NWP-0476 can be used for relapsed T-acute lymphoblastic leukemia (T-ALL) research[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C47H53ClN8O8S |
|---|---|
| Molecular Weight | 925.49 |